Program Description: 

Accreditation

For Physician Assistants:

This program has been reviewed and is approved for a maximum of 1.00 hour of AAPA Category 1 CME credit by the Physician Assistant Review Panel. Physician assistants should claim only those hours actually spent participating in the CME activity. This program was planned in accordance with AAPA's CME Standards for Live Programs and for Commercial Support of Live Programs.
 

For Nursing Contact Hours: (1 Hour)

Froedtert & the Medical College of Wisconsin is an approved provider of continuing nursing education by the Wisconsin Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation

Successful completion of the activity will require attendance at the entire activity and completion of an evaluation form.

Please contact:  Katie Worzalla at 805-1523 or kworzalla@mcw.edu for any questions or concerns

Target audience: 

Physician Assistants

Nurses

Staff caring for blood and marrow transplant patients

Learning objectives: 

1. Review clinical outcome updates for CD19 CAR-T therapies for B cell malignancies

2. Review future directions in CAR-T cell treatments: Multi-targeted CARs, Armored CARs and Novel Agents

Faculty & credentials: 

Presenter(s):

Nirav Shah, MD, Professor and Cell Therapy Lab Director, Division Hematology/Oncology, Medical College of Wisconsin  

All persons in control of content have NO relevant financial relationships to disclose.

Contact

Name: 
Valerie Ehrlich
Phone number: 
+1 (414) 907-0999

Current Applications & Future Directions of CAR-T Therapies in B Cell Malignancies

 

Speaker(s):

Nirav Shah, MD, Professor and Cell Therapy Lab Director, Division Hematology/Oncology, Medical College of Wisconsin  

 

 

 

Session date: 
04/25/2019 - 3:00pm to 4:00pm CDT
Location: 
Cancer Center
8800 W. Doyne Avenue
Conference Room M
Milwaukee, WI 53226
United States
  • 1.00 PA
    PA credit.

Please login or register to take this course.